<SEC-DOCUMENT>0001193125-24-063618.txt : 20240308
<SEC-HEADER>0001193125-24-063618.hdr.sgml : 20240308
<ACCEPTANCE-DATETIME>20240308160102
ACCESSION NUMBER:		0001193125-24-063618
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240306
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240308
DATE AS OF CHANGE:		20240308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Equillium, Inc.
		CENTRAL INDEX KEY:			0001746466
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				821554746
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38692
		FILM NUMBER:		24734195

	BUSINESS ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 105
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		(858) 412-5302

	MAIL ADDRESS:	
		STREET 1:		2223 AVENIDA DE LA PLAYA
		STREET 2:		SUITE 105
		CITY:			LA JOLLA
		STATE:			CA
		ZIP:			92037
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d797682d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:eq="http://equilliumbio.com/20240306" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_SecurityExchangeName" name="dei:SecurityExchangeName" contextRef="duration_2024-03-06_to_2024-03-06">NASDAQ</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-263">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-03-06_to_2024-03-06">0001746466</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="eq-20240306.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-03-06_to_2024-03-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001746466</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-03-06</xbrli:startDate> <xbrli:endDate>2024-03-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-274">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt:datemonthdayyearen" id="ixv-275">March 6, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-276">Equillium, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:stateprovnameen" id="ixv-277">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-278">001-38692</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-279">82-1554746</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-280">2223 Avenida de la</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-281">Playa</ix:nonNumeric><br/></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-282">Suite 105</ix:nonNumeric><br/><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-283">La Jolla</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:stateprovnameen" id="ixv-284">California</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-285">92037</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-286">(858)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-287">412-5302</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:boolballotbox" id="ixv-288">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:boolballotbox" id="ixv-289">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:boolballotbox" id="ixv-290">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:boolballotbox" id="ixv-291">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-292">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-293">EQ</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <span style=" -sec-ix-hidden:Hidden_dei_SecurityExchangeName">Nasdaq Capital Market</span> </td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-03-06_to_2024-03-06" format="ixt-sec:boolballotbox" id="ixv-294">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;6, 2024, the Board of Directors (the &#8220;Board&#8221;) of Equillium, Inc. (the &#8220;Company&#8221;) appointed Penny Tom, the Company&#8217;s Senior Vice President, Finance, as the Company&#8217;s principal accounting officer (to replace Jason Keyes, the Company&#8217;s Chief Financial Officer, in such role). There have been no other changes to Mr.&#160;Keyes&#8217; employment or roles with the Company. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Tom, age 60, has served as the Company&#8217;s Senior Vice President, Finance since April 2022 and served as the Company&#8217;s Vice President, Finance from January 2019 to April 2022. Ms.&#160;Tom is a certified public accountant and received her B.S. in accounting from The University of Montana - College of Business. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&#160;Tom has no family relationships with any of the Company&#8217;s directors or executive officers, and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of <span style="white-space:nowrap">Regulation&#160;S-K.&#160;In</span> addition, there are no arrangements or understandings between Ms.&#160;Tom and any other person pursuant to which she was selected to her role with the Company. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&#160;6, 2024, upon the recommendation of the Compensation Committee of the Board, the Board adopted and approved the Company&#8217;s 2024 Inducement Plan (the &#8220;Inducement Plan&#8221;) to reserve 1,500,000 shares of the Company&#8217;s common stock to be used exclusively for grants of equity awards to individuals that were not previously employees or directors of the Company (or who are returning to employment following a<span style="font-style:italic">&#160;bona fide</span>&#160;period <span style="white-space:nowrap">of&#160;non-employment),&#160;as</span> an inducement material to the individual&#8217;s entry into employment with the Company, pursuant to Nasdaq Listing Rule 5635(c)(4). The Inducement Plan was adopted and approved without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4). In addition, the Board adopted and approved forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise for use with the Inducement Plan. The terms and conditions of the Inducement Plan are substantially similar to the Company&#8217;s stockholder-approved 2018 Equity Incentive Plan. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A complete copy of the Inducement Plan is filed herewith as Exhibit 99.1. The above summary of the Inducement Plan does not purport to be complete and is qualified in its entirety by reference to such exhibit. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit</span> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d797682dex991.htm">Equillium, Inc. 2024 Inducement Plan and Forms of Stock Option Grant Notice, Option Agreement, and Notice of Exercise thereunder. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Equillium, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Dated: March&#160;8, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jason A. Keyes</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Jason A. Keyes</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d797682dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>QUILLIUM</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2024 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>: March&nbsp;6,
2024 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>G<SMALL>ENERAL</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Eligible Award Recipients.</B> The only persons eligible to receive grants of Awards under this Plan are individuals who satisfy
the standards for inducement grants under Nasdaq Marketplace Rule 5635(c)(4) or 5635(c)(3), if applicable, and the related guidance under Nasdaq IM <FONT STYLE="white-space:nowrap">5635-1,</FONT> and any successor rule or guidance. A person who
previously served as an Employee or Director will not be eligible to receive Awards under the Plan, other than following a <I>bona fide</I> period of <FONT STYLE="white-space:nowrap">non-employment.</FONT> Persons eligible to receive grants of
Awards under this Plan are referred to in this Plan as &#147;<B><I>Eligible Employees</I></B>.&#148; These Awards must be approved by either a majority of the Company&#146;s &#147;Independent Directors&#148; (as such term is defined in Nasdaq
Marketplace Rule 5605(a)(2)) (&#147;<B><I>Independent Directors</I></B>&#148;) or the Company&#146;s compensation committee, provided such committee is comprised solely of Independent Directors of the Company (the &#147;<B><I>Independent
Compensation Committee</I></B>&#148;) in order to comply with the exemption from the stockholder approval requirement for &#147;inducement grants&#148; provided under Rule 5635(c)(4) of the Nasdaq Marketplace Rules. Nasdaq Marketplace Rule
5635(c)(4) and the related guidance under Nasdaq IM <FONT STYLE="white-space:nowrap">5635-1</FONT> (together with any analogous rules or guidance effective after the date hereof, the &#147;<B><I>Inducement Award Rules</I></B>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Purpose.</B> The Plan, through the grant of Awards, is intended to (i)&nbsp;provide a material inducement for certain individuals
to enter into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Marketplace Rules, (ii)&nbsp;help the Company secure and retain the services of Eligible Employees, (iii)&nbsp;provide incentives for such persons to exert
maximum efforts for the success of the Company and any Affiliate, and (iv)&nbsp;provide a means by which such persons may benefit from increases in value of the shares of Common Stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Available Awards.</B> The Plan provides for the grant of the following Awards: (i)&nbsp;Nonstatutory Stock Options;
(ii)&nbsp;SARs; (iii) Restricted Stock Awards; (iv)&nbsp;RSU Awards; (v)&nbsp;Performance Cash Awards; (vi)&nbsp;Performance Stock Awards; and (vii)&nbsp;Other Stock Awards. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>A<SMALL>DMINISTRATION</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Administration by Board.</B> The Board will administer the Plan; provided, however, that Awards may only be granted by either
(i)&nbsp;a majority of the Company&#146;s Independent Directors or (ii)&nbsp;the Independent Compensation Committee. Subject to those constraints and the other constraints of the Inducement Award Rules, the Board may delegate administration of the
Plan to a Committee or Committees, as provided in Section&nbsp;2(e). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Eligible Award Recipients. </B>Awards may only be
granted to persons who are Eligible Employees described in Section&nbsp;1(a) of the Plan, where the Award is an inducement material to the individual&#146;s entering into employment with the Company or an Affiliate within the meaning of Rule
5635(c)(4) of the Nasdaq Marketplace Rules or is otherwise permitted pursuant to Rule 5635(c) of the Nasdaq Marketplace Rules. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B>
<B>Approval Requirements</B>. All Awards must be granted either by a majority of the Company&#146;s Independent Directors or by the Independent Compensation Committee. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Powers of Board.</B> The Board will have the power, subject to, and within the
limitations of, the express provisions of the Plan and the Inducement Award Rules: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> To determine (A)&nbsp;who will be granted
Awards; (B)&nbsp;when and how each Award will be granted; (C)&nbsp;what type of Award will be granted; (D)&nbsp;the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive
cash or Common Stock under the Award; (E)&nbsp;the number of shares of Common Stock subject to, or the cash value of, an Award; (F)&nbsp;the Fair Market Value applicable to a Stock Award; and (G)&nbsp;the terms of any Performance Award that is not
valued in whole or in part by reference to, or otherwise based on, the Common Stock, including the amount of cash payment or other property that may be earned and the timing of payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for
administration of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the
extent it will deem necessary or expedient to make the Plan or Award fully effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> To settle all controversies regarding
the Plan and Awards granted under it. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> To accelerate, in whole or in part, the time at which an Award may be exercised or vest
(or the time at which cash or shares of Common Stock may be issued in settlement thereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> To prohibit the exercise of any
Option, SAR or other exercisable Award during a period of up to thirty days prior to the consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash
dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock including any Corporate Transaction, for reasons of administrative convenience. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or
termination of the Plan will not materially impair a Participant&#146;s rights under the Participant&#146;s then-outstanding Award without the Participant&#146;s written consent except as provided in subsection (ix)&nbsp;below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vii)</B> To amend the Plan in any respect deemed necessary or advisable, including, without limitation, by adopting amendments relating to
certain nonqualified deferred compensation under Section&nbsp;409A of the Code and/or ensuring that the Plan and Awards are exempt from or compliant with the requirements for nonqualified deferred compensation under Section&nbsp;409A of the Code,
subject to the limitations, if any, of applicable law. The Company will seek stockholder approval of any amendment of the Plan if required by applicable law or listing requirements. Except as otherwise provided in the Plan or an Award Agreement, no
amendment of the Plan will materially impair a Participant&#146;s rights under an outstanding Award without the Participant&#146;s written consent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(viii)</B> To the extent required by applicable law, to submit any amendment to the Plan for stockholder approval. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ix)</B> To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not
limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion; <I>provided however,</I> that a
Participant&#146;s rights under any Award will not be impaired by any such amendment unless (A)&nbsp;the Company requests the consent of the affected Participant, and (B)&nbsp;such Participant consents in writing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(x)</B> Generally, to exercise such powers and to perform such acts as deemed necessary
or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(xi)</B> To adopt such procedures and <FONT STYLE="white-space:nowrap">sub-plans</FONT> as are necessary or appropriate to permit
participation in the Plan by Employees who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Award Agreement that are required for
compliance with the laws of the relevant foreign jurisdiction). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(xii)</B> To effect, with the consent of any adversely affected
Participant, and subject to stockholder approval if required by applicable law or listing requirements (including the Inducement Award Rules)&nbsp;(A) the reduction of the exercise, purchase or strike price of any outstanding Stock Award;
(B)&nbsp;the cancellation of any outstanding Stock Award and the grant in substitution therefor of a new (1)&nbsp;Option or SAR, (2)&nbsp;Restricted Stock Award, (3)&nbsp;Restricted Stock Unit Award, (4)&nbsp;Other Stock Award, (5)&nbsp;cash and/or
(6)&nbsp;other valuable consideration determined by the Board, in its sole discretion, with any such substituted award (x)&nbsp;covering the same or a different number of shares of Common Stock as the cancelled Stock Award and (y)&nbsp;granted under
the Plan or another equity or compensatory plan of the Company; or (C)&nbsp;any other action that is treated as a repricing under generally accepted accounting principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in the foregoing to the contrary, (1)&nbsp;a Participant&#146;s rights will not be deemed to have been impaired by any such amendment
if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially impair the Participant&#146;s rights, and (2)&nbsp;subject to the limitations of applicable law, if any, the Board may amend the terms of any
one or more Awards without the affected Participant&#146;s consent (A)&nbsp;to clarify the manner of exemption from, or to bring the Award into compliance with, Section&nbsp;409A of the Code; or (B)&nbsp;to comply with other applicable laws or
listing requirements. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(e)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Delegation to Committee. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <B>General.</B> Subject to the terms of Section&nbsp;2(a), the Board may delegate some or all of the administration of the Plan to a
Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee,
including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as
applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority to
concurrently administer the Plan with the Committee and may, at any time, subject to the Inducement Award Rules, revest in the Board some or all of the powers previously delegated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> Compliance.</B> In cases where a Committee&#146;s actions are required to
comply with Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> the relevant Committee shall consist solely of two or more directors that qualify as <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors, in accordance with Rule <FONT
STYLE="white-space:nowrap">16b-3.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Effect of Board&#146;s Decision.</B> All determinations, interpretations and
constructions made by the Board or any Committee in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>.<SUP
STYLE="font-size:75%; vertical-align:top"> </SUP> </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Share Reserve. </B>The aggregate number of shares of
Common Stock that may be issued pursuant to Stock Awards will not exceed 1,500,000 shares (the &#147;<B><I>Share Reserve</I></B>&#148;), subject to adjustment as necessary to implement any Capitalization Adjustments. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For clarity, the Share Reserve in this Section&nbsp;3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to
the Plan. Accordingly, this Section&nbsp;3(a) does not limit the granting of Stock Awards except as provided in Section&nbsp;7(a). Shares may be issued in connection with a merger or acquisition as permitted by Nasdaq Listing Rule 5635(c) or, if
applicable, NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Reversion of Shares to the Share Reserve. </B>If a Stock Award or any portion thereof (i)&nbsp;expires or otherwise terminates
without all of the shares covered by such Stock Award having been issued or (ii)&nbsp;is settled in cash (<I>i.e.</I>, the Participant receives cash rather than stock), such expiration, termination or settlement will not reduce (or otherwise offset)
the number of shares of Common Stock that may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased or reacquired by the Company for any reason, including
because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under the Plan. Any
shares reacquired by the Company in satisfaction of tax withholding obligations on a Stock Award or as consideration for the exercise, strike or purchase price of a Stock Award will again become available for issuance under the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Source of Shares.</B> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock,
including shares repurchased by the Company on the open market or otherwise. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>E<SMALL>LIGIBILITY</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards may only be granted to persons who are Eligible Employees; <U>provided however</U>, that Awards may not be granted to Eligible Employees
who are providing Continuous Service only to any &#147;parent&#148; of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i)&nbsp;the stock underlying such Awards is treated as &#147;service recipient stock&#148; under
Section&nbsp;409A of the Code (for example, because the Awards are granted pursuant to a corporate transaction such as a spin off transaction), or (ii)&nbsp;the Company, in consultation with its legal counsel, has determined that such Awards are
otherwise exempt from or comply with the distribution requirements of, Section&nbsp;409A of the Code. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>P<SMALL>ROVISIONS</SMALL> R<SMALL>ELATING</SMALL> <SMALL>TO</SMALL> O<SMALL>PTIONS</SMALL>
<SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL> R<SMALL>IGHTS</SMALL>. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Option or SAR will
be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be Nonstatutory Stock Options, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common
Stock purchased on exercise. The provisions of separate Options or SARs need not be identical; <I>provided, however</I>, that each Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Award
Agreement or otherwise) the substance of each of the following provisions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Term.</B> No Option or SAR will be exercisable
after the expiration of ten (10)&nbsp;years from the date of its grant or such shorter period specified in the Award Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Exercise Price.</B> The exercise or strike price of each Option or SAR will be
not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the
Fair Market Value of the Common Stock subject to the Award if such Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a corporate transaction and in a manner consistent with the
provisions of Section&nbsp;409A of the Code. Each SAR will be denominated in shares of Common Stock equivalents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Exercise
Price Procedure and Purchase Price for Options.</B> To exercise an Option, the Participant must provide notice of exercise to the Plan administrator in accordance with the procedures specified in the Option Agreement or otherwise provided by the
Company. The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set
forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use
a particular method of payment. The permitted methods of payment are as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> by cash, check, bank draft or money order
payable to the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that,
prior to the issuance of the stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds (a
&#147;cashless exercise&#148; program); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> by delivery to the Company (either by actual delivery or attestation) of shares of
Common Stock that are already owned by the Participant free and clear of any liens, claims, encumbrances or security interests, with a Fair Market Value on the date of exercise that does not exceed the exercise price, provided that (A)&nbsp;at the
time of exercise the Common Stock is publicly traded, (B)&nbsp;any remaining balance of the exercise price not satisfied by such delivery is paid by the Participant in cash or other permitted form of payment, (C)&nbsp;such delivery would not violate
any applicable law or agreement restricting the redemption of the Common Stock, (D)&nbsp;any certificated shares are endorsed or accompanied by an executed assignment separate from certificate, and (E)&nbsp;such shares have been held by the
Participant for any minimum period necessary to avoid adverse accounting treatment as a result of such delivery; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> by a
&#147;net exercise&#148; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value on the date of exercise that does not exceed
the aggregate exercise price; <U>provided, however</U>, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of
whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A)&nbsp;shares issuable upon exercise are used to pay the exercise price pursuant to the &#147;net
exercise,&#148; (B) shares are delivered to the Participant as a result of such exercise, and (C)&nbsp;shares are withheld to satisfy tax withholding obligations; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Exercise and Payment of a SAR.</B> To exercise any outstanding SAR, the
Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater
than an amount equal to the excess of (A)&nbsp;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under
such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B)&nbsp;the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The
appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Award Agreement evidencing such SAR. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Transferability of Options and SARs.</B> The Board may, in its sole discretion, impose such limitations on the transferability of
Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions on the transferability of Options and SARs will apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>)</B> <B>Restrictions on Transfer</B>. An Option or SAR will not be transferable except by will or by the laws of descent
and distribution (or pursuant to subsections (ii)&nbsp;and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant. The Board may permit transfer of the Option or SAR in a manner that is not prohibited by
applicable tax and securities laws. Except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> <B>Domestic Relations Orders</B>. Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be
transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> <B>Beneficiary Designation</B>. Subject to the approval of the Board or a duly authorized Officer, a Participant may, by
delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, on the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common
Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#146;s estate will be entitled to exercise the Option or SAR and
receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with
the provisions of applicable laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Vesting Generally.</B> The total number of shares of Common Stock subject to an Option or
SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the
satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section&nbsp;5(f) are subject to any Option or SAR provisions governing the
minimum number of shares of Common Stock as to which an Option or SAR may be exercised. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> <B>Termination of Continuous
Service.</B> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates (other than for Cause and other than upon the
Participant&#146;s death or Disability), the Participant may exercise such Participant&#146;s Option or SAR (to the extent that the Participant was entitled to exercise such Award as of the date of termination of Continuous Service) within the
period of time ending on the earlier of (i)&nbsp;the date that is three (3)&nbsp;months following the termination of the Participant&#146;s Continuous Service (or such longer or shorter period specified in the applicable Award Agreement, which
period will not be less than thirty (30)&nbsp;days if necessary to comply with applicable laws unless such termination is for Cause) and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after
termination of Continuous Service, the Participant does not exercise such Participant&#146;s Option or SAR (as applicable) within the applicable time frame, the Option or SAR will terminate. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> <B>Extension of Termination Date.</B> Except as otherwise provided in the
applicable Award Agreement or other written agreement between the Participant and the Company, if the exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause and other than upon the
Participant&#146;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier
of (i)&nbsp;the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination exercise period after the termination of the Participant&#146;s Continuous Service during which the exercise of the Option
or SAR would not be in violation of such registration requirements, and (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a Participant&#146;s Award
Agreement, if the sale of any Common Stock received on exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause) would violate the Company&#146;s insider trading policy, then the
Option or SAR will terminate on the earlier of (i)&nbsp;the expiration of a period of months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#146;s Continuous Service
during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#146;s insider trading policy, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable
Award Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>)</B> <B>Disability of Participant.</B> Except as otherwise provided in the applicable Award Agreement
or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise such Participant&#146;s Option or SAR (to the extent
that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date twelve (12)&nbsp;months following such termination
of Continuous Service (or such longer or shorter period specified in the Award Agreement, which period will not be less than six (6)&nbsp;months if necessary to comply with applicable laws) and (ii)&nbsp;the expiration of the term of the Option or
SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise such Participant&#146;s Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> <B>Death of Participant.</B> Except as otherwise provided in the applicable Award Agreement or other agreement between the
Participant and the Company, if (i)&nbsp;a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s death, or (ii)&nbsp;the Participant dies within the period (if any) specified in the Award Agreement for exercisability
after the termination of the Participant&#146;s Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of death) by the
Participant&#146;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#146;s death, but only within the period ending on the
earlier of (i)&nbsp;the date eighteen (18)&nbsp;months following the date of death (or such longer or shorter period specified in the Award Agreement, which period will not be less than six (6)&nbsp;months if necessary to comply with applicable
laws) and (ii)&nbsp;the expiration of the term of such Option or SAR as set forth in the Award Agreement. If, after the Participant&#146;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable)
will terminate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> <B>Termination for Cause.</B> Except as explicitly provided otherwise in a Participant&#146;s Award Agreement
or other individual written agreement between the Company or any Affiliate and the Participant, if a Participant&#146;s Continuous Service is terminated for Cause, the Option or SAR will terminate immediately upon such Participant&#146;s termination
of Continuous Service, and the Participant will be prohibited from exercising such Participant&#146;s Option or SAR from and after the time of such termination of Continuous Service. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> <B><FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employees</B>. If an Option
or SAR is granted to an Employee who is a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock
until at least six (6)&nbsp;months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i)&nbsp;if such <FONT
STYLE="white-space:nowrap">non-exempt</FONT> Employee dies or suffers a Disability, (ii)&nbsp;upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii)&nbsp;upon a Change in Control, or (iv)&nbsp;upon
the Participant&#146;s retirement (as such term may be defined in the Participant&#146;s Award Agreement, in another agreement between the Participant and the Company, or, if no such definition, in accordance with the Company&#146;s then current
employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six&nbsp;(6) months following the date of grant. The foregoing provision is intended to operate so that any income derived by a <FONT
STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise or vesting of an Option or SAR will be exempt from such Participant&#146;s regular rate of pay. To the extent permitted and/or required for compliance with the
Worker Economic Opportunity Act to ensure that any income derived by a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the
employee&#146;s regular rate of pay, the provisions of this Section&nbsp;5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>P<SMALL>ROVISIONS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>WARDS</SMALL> O<SMALL>THER</SMALL>
<SMALL>THAN</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> SAR<SMALL>S</SMALL>. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Restricted Stock
Awards.</B> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. To the extent consistent with the Company&#146;s bylaws, at the Board&#146;s election, shares of Common
Stock may be (i)&nbsp;held in book entry form subject to the Company&#146;s instructions until any restrictions relating to the Restricted Stock Award lapse; or (ii)&nbsp;evidenced by a certificate, which certificate will be held in such form and
manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted Stock
Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Consideration.</B> A Restricted Stock Award may be awarded in consideration for (A)&nbsp;cash, check, bank draft or money order
payable to the Company, (B)&nbsp;past or future services to the Company or an Affiliate, or (C)&nbsp;any other form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> <B>Vesting. </B>Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the
Company in accordance with a vesting schedule to be determined by the Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> <B>Termination of Participant&#146;s Continuous
Service.</B> If a Participant&#146;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant as of the date of termination of
Continuous Service under the terms of the Restricted Stock Award Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> <B>Transferability.</B> Rights to acquire shares
of Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so
long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> <B>Dividends. </B>A Restricted Stock Award Agreement may provide that any
dividends paid on Restricted Stock will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Restricted Stock Unit Awards. </B>Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and
conditions as the Board deems appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each
Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>)</B> <B>Consideration.</B> At the time of grant of a Restricted Stock Unit Award, the Board will determine the
consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any) by the Participant for each share of Common Stock subject to a
Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> <B>Vesting. </B>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions
to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> <B>Payment</B>. A
Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> <B>Additional Restrictions. </B>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems
appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> <B>Dividend Equivalents. </B>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock
Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock
Unit Award in such manner as determined by the Board. Any additional shares of Common Stock covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the
underlying Restricted Stock Unit Award Agreement to which they relate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> <B>Termination of Participant</B><B>&#146;</B><B>s
Continuous Service. </B>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement or other written agreement between a Participant and the Company or an Affiliate, such portion of the Restricted Stock Unit Award that has
not vested will be forfeited upon the Participant&#146;s termination of Continuous Service. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Performance Awards</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>i</B><B>)</B> <B>Performance Stock Awards</B>. A Performance Stock Award is a Stock Award that is payable (including that may be
granted, may vest or may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may, but need not, require the Participant&#146;s completion of a specified period of
Continuous Service. The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, the other terms and conditions of such Performance Stock Award, and the measure of whether and to what degree such
Performance Goals have been attained will be conclusively determined by the Board or Committee, in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board or the Committee may
determine that cash may be used in payment of Performance Stock Awards. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> <B>Performance Cash Awards</B>. A Performance Cash
Award is a cash award that is payable contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Cash Award may also require the completion of a specified period of Continuous Service. At the time of grant
of a Performance Cash Award, the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively
determined by the Board or Committee, in its sole discretion. The Board or Committee may specify the form of payment of Performance Cash Awards, which may be cash or other property, or may provide for a Participant to have the option for such
Participant&#146;s Performance Cash Award, or such portion thereof as the Board may specify, to be paid in whole or in part in cash or other property. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> <B>Board Discretion</B>. The Board retains the discretion to adjust or eliminate the compensation or economic benefit due upon
attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding to the
degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Other
Stock Awards</B>. Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less
than 100% of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under Section&nbsp;5 and the preceding provisions of this Section&nbsp;6. Subject to the provisions
of the Plan, the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted
pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>.
</B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Availability of Shares.</B> The Company will keep available at all times the number of shares of
Common Stock reasonably required to satisfy its obligations to issue shares pursuant to then-outstanding Stock Awards. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>
<B>Securities Law Compliance.</B> The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan, as necessary, such authority as may be required to grant Stock Awards and to issue and sell shares of
Common Stock upon exercise or vesting of the Stock Awards; <I>provided, however</I>, that this undertaking will not require the Company to register under the Securities Act or other securities or applicable laws, the Plan, any Stock Award or any
Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems
necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Stock Awards unless and until such
authority is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant to the Award if such grant or issuance would be in violation of any applicable securities law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>No Obligation to Notify or Minimize Taxes. </B>The Company will have no duty
or obligation to any Participant to advise such holder as to the tax treatment or time or manner of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending
termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>M<SMALL>ISCELLANEOUS</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Use of Proceeds from Sales of Common Stock. </B>Proceeds from the sale of shares of Common Stock pursuant to Stock Awards will
constitute general funds of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Corporate Action Constituting Grant of Awards.</B> Corporate action constituting a
grant by the Company of an Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Award is
communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action approving the grant contain terms (e.g., exercise price,
vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records will
control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Stockholder Rights.</B> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect
to, any shares of Common Stock subject to an Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii)&nbsp;the
issuance of the Common Stock subject to such Award has been entered into the books and records of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>No Employment
or Other Service Rights.</B> Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or
an Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate (i)&nbsp;the employment of an Employee with or without notice and with or without cause, (ii)&nbsp;the
service of a Consultant pursuant to the terms of such Consultant&#146;s agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the
corporate law of the state or foreign jurisdiction in which the Company or the Affiliate is domiciled or incorporated, as the case may be. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> <B>Change in Time Commitment</B>. In the event a Participant&#146;s regular level of time commitment in the performance of such
Participant&#146;s services for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time
Employee or takes an extended leave of absence) after the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x)&nbsp;make a corresponding reduction in the number of shares or cash amount subject to any
portion of such Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y)&nbsp;in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Award. In
the event of any such reduction, the Participant will have no right with respect to any portion of the Award that is so reduced or extended. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> <B>Investment Assurances.</B> The Company may require a Participant, as a
condition of exercising or acquiring Common Stock under any Award, (i)&nbsp;to give written assurances satisfactory to the Company as to the Participant&#146;s knowledge and experience in financial and business matters and/or to employ a purchaser
representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that such Participant is capable of evaluating, alone or together with the purchaser representative, the merits and
risks of exercising the Award; and (ii)&nbsp;to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Award for the Participant&#146;s own account and not with any present intention
of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative if (A)&nbsp;the issuance of the shares upon the exercise or acquisition of Common Stock
under the Stock Award has been registered under a then currently effective registration statement under the Securities Act, or (B)&nbsp;as to any particular requirement, a determination is made by counsel for the Company that such requirement need
not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to
comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B>
<B>Withholding Obligations.</B> Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to an Award by any of the following means or by a
combination of such means: (i)&nbsp;causing the Participant to tender a cash payment; (ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Stock Award;
<I>provided, however, </I>that no shares of Common Stock are withheld with a value exceeding the maximum amount of tax required to be withheld by law (or such lesser amount as may be necessary to avoid classification of the Stock Award as a
liability for financial accounting purposes); (iii) withholding cash from an Award settled in cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; (v)&nbsp;a &#147;sell to cover&#148; arrangement; or
(vi)&nbsp;by such other method as may be set forth in the Award Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> <B>Electronic Delivery</B>. Any reference herein to
a &#147;written&#148; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#146;s intranet (or other shared electronic medium
controlled by the Company to which the Participant has access). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> <B>Deferrals.</B> To the extent permitted by applicable law,
the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish programs and procedures for
deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section&nbsp;409A of the Code. Consistent with Section&nbsp;409A of the Code, the Board may provide for distributions while a Participant is
still an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the
Participant&#146;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> <B>Clawback</B><B>/Recovery</B>. All Awards granted under the Plan will be
subject to recoupment in accordance with the Company&#146;s current clawback policies, as they may be amended from time to time, including the clawback policy that the Company adopted as required by the Dodd-Frank Wall Street Reform and Consumer
Protection Act and related stock exchange listing standards. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines necessary or appropriate, including but not limited
to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy will be an event giving rise to
a right to resign for &#147;good reason&#148; or &#147;constructive termination&#148; (or similar term) under any agreement with the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> <B>Compliance with Section</B><B></B><B>&nbsp;409A of the Code. </B>Unless otherwise expressly provided for in an Award Agreement,
the Plan and Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section&nbsp;409A of the Code, and, to the extent not so exempt, in compliance with
Section&nbsp;409A of the Code. If the Board determines that any Award granted hereunder is not exempt from and is therefore subject to Section&nbsp;409A of the Code, the Award Agreement evidencing such Award will incorporate the terms and conditions
necessary to avoid the consequences specified in Section&nbsp;409A(a)(1) of the Code, and to the extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award Agreement.
Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#147;deferred
compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified employee&#148; for purposes of Section&nbsp;409A of the Code, no distribution or payment of any amount that is due because of a &#147;separation from service&#148; (as
defined in Section&nbsp;409A of the Code without regard to alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#146;s &#147;separation from service&#148; or, if
earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in a manner that complies with Section&nbsp;409A of the Code, and any amounts so deferred will be paid in a lump sum on the day after such six month
period elapses, with the balance paid thereafter on the original schedule. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL>
C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL> C<SMALL>ORPORATE</SMALL> E<SMALL>VENTS</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> <B>Capitalization Adjustments</B>. In the event of a Capitalization Adjustment, the Board will appropriately and proportionately
adjust: (i)&nbsp;the class(es) and maximum number of securities subject to the Plan pursuant to Section&nbsp;3(a) and (ii)&nbsp;the class(es) and number of securities and exercise price, strike price or purchase price of stock subject to outstanding
Stock Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B>
<B>Dissolution</B>. Except as otherwise provided in the Stock Award Agreement, in the event of a Dissolution of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not
subject to a forfeiture condition or the Company&#146;s right of repurchase) will terminate immediately prior to the completion of such Dissolution, and the shares of Common Stock subject to the Company&#146;s repurchase rights or subject to a
forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service; <I>provided, however,</I> that the Board may, in its sole discretion, cause some or
all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the Dissolution is completed but contingent on its
completion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Transaction.</B> The following provisions will apply to Stock Awards in the event of a Transaction unless
otherwise provided in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the Participant or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the
event of a Transaction, then, notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Transaction: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company) to
assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Transaction); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> arrange for the assignment of any reacquisition or repurchase rights held by the
Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be
exercised) to a date prior to the effective time of such Transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five days prior to the effective date of the Transaction), with such Stock Award
terminating if not exercised (if applicable) at or prior to the effective time of the Transaction; <I>provided, however</I>, that the Board may require Participants to complete and deliver to the Company a notice of exercise before the effective
date of a Transaction, which exercise is contingent upon the effectiveness of such Transaction; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> arrange for the lapse, in
whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> cancel or
arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider
appropriate; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(vi)</B> make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A)&nbsp;the
value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Transaction, over (B)&nbsp;any exercise price payable by such holder in connection with such exercise. For
clarity, this payment may be $0 if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Company&#146;s Common Stock
in connection with the Transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board need not
take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> <B>Change in Control.</B> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a
Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such
acceleration will automatically occur. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>P<SMALL>LAN</SMALL> T<SMALL>ERM</SMALL>; E<SMALL>ARLIER</SMALL> T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL>
S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may suspend or
terminate the Plan at any time. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. Suspension or termination of the Plan will not impair rights and obligations under any Award granted while the Plan is in
effect except with the written consent of the affected Participant or as otherwise permitted in the Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>E<SMALL>XISTENCE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>; T<SMALL>IMING</SMALL>
<SMALL>OF</SMALL> F<SMALL>IRST</SMALL> G<SMALL>RANT</SMALL> <SMALL>OR</SMALL> E<SMALL>XERCISE</SMALL>. </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan will
come into existence on the date on which it is adopted by the Board. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>C<SMALL>HOICE</SMALL> <SMALL>OF</SMALL> L<SMALL>AW</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The laws of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without
regard to that state&#146;s conflict of laws rules. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>D<SMALL>EFINITIONS</SMALL>. As used in the Plan, the following definitions will apply to the capitalized
terms indicated below: </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> &#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any
&#147;parent&#148; or &#147;subsidiary&#148; of the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is
determined within the foregoing definition. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> &#147;<B><I>Award</I></B>&#148; means a Stock Award or a Performance Cash Award.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> &#147;<B><I>Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the terms
and conditions of an Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> &#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> &#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other events that occur with respect to,
the Common Stock subject to the Plan or subject to any Stock Award after the date on which the Plan is adopted by the Board without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization,
reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar
equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible
securities of the Company will not be treated as a Capitalization Adjustment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> &#147;<B><I>Cause</I></B>&#148;<B><I>
</I></B>shall have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of
the following events: (i)&nbsp;such Participant&#146;s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (ii)&nbsp;such Participant&#146;s attempted
commission of, or participation in, a fraud or act of dishonesty against the Company; (iii)&nbsp;such Participant&#146;s intentional, material violation of any contract or agreement between the Participant and the Company or of any statutory duty
owed to the Company; (iv)&nbsp;such Participant&#146;s unauthorized use or disclosure of the Company&#146;s confidential information or trade secrets; or (v)&nbsp;such Participant&#146;s gross misconduct. The determination that a termination of the
Participant&#146;s Continuous Service is either for Cause or without Cause shall be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for
the purposes of outstanding Awards held by such Participant shall have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> &#147;<B><I>Change in Control</I></B>&#148; means the occurrence, in a single
transaction or in a series of related transactions, of any one or more of the following events:<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the
combined voting power of the Company&#146;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A)&nbsp;on account of the
acquisition of securities of the Company directly from the Company, (B)&nbsp;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#146;s
securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, (C)&nbsp;on account of the acquisition of securities of the Company by any
individual who is, on the IPO Date, either an executive officer or a Director (either, an &#147;<B><I>IPO Investor</I></B>&#148;) and/or any entity in which an IPO Investor has a direct or indirect interest (whether in the form of voting rights or
participation in profits or capital contributions) of more than 50% (collectively, the &#147;<B><I>IPO Entities</I></B>&#148;) or on account of the IPO Entities continuing to hold shares that come to represent more than 50% of the combined voting
power of the Company&#146;s then outstanding securities as a result of the conversion of any class of the Company&#146;s securities into another class of the Company&#146;s securities having a different number of votes per share pursuant to the
conversion provisions set forth in the Company&#146;s Amended and Restated Certificate of Incorporation; or (D)&nbsp;solely because the level of Ownership held by any Exchange Act Person (the &#147;<B><I>Subject Person</I></B>&#148;) exceeds the
designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur
(but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or
other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than 50% of
the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B)&nbsp;more than 50% of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation
or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; <I>provided, however</I>, that a merger, consolidation or
similar transaction will not constitute a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are owned by the IPO
Entities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the
consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined
voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or
other disposition; <I>provided, however</I>, that a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute a Change in Control under this
prong of the definition if the outstanding voting securities representing more than 50% of the combined voting power of the acquiring Entity or its parent are owned by the IPO Entities; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> the stockholders of the Company approve or the Board approves a plan of complete
dissolution or liquidation of the Company, or a complete dissolution or liquidation of the Company will otherwise occur, except for a liquidation into a parent corporation; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> individuals who, on the IPO Date, are members of the Board (the
&#147;<B><I>Incumbent</I></B><B><I></I></B><B><I>&nbsp;Board</I></B>&#148;) cease for any reason to constitute at least a majority of the members of the Board; <I>provided, however,</I> that if the appointment or election (or nomination for
election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing definition or any other provision of the Plan, (A)&nbsp;the term Change in Control will not include a sale of
assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company and (B)&nbsp;the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any
Affiliate and the Participant will supersede the foregoing definition with respect to Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change in Control or any analogous term is set forth in such an individual
written agreement, the foregoing definition will apply. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If required for compliance with Section&nbsp;409A of the Code, in no event will an
event be deemed a Change in Control if such event is not also a &#147;change in the ownership of&#148; the Company, a &#147;change in the effective control of&#148; the Company or a &#147;change in the ownership of a substantial portion of the
assets of&#148; the Company, each as determined under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> (without regard to any alternative definition thereunder). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> &#147;<B><I>Code</I></B>&#148; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and
guidance thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> &#147;<B><I>Committee</I></B>&#148; means a committee of one or more Independent Directors to whom
authority has been delegated by the Board in accordance with Section&nbsp;2(e). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> &#147;<B><I>Common Stock</I></B>&#148; means
the common stock of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(k)</B> &#147;<B><I>Company</I></B>&#148; means Equillium, Inc., a Delaware corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(l)</B> &#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is (i)&nbsp;engaged by the Company or an Affiliate
to render consulting or advisory services and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a
fee for such service, will not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan.<B><I> </I></B>Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form <FONT
STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#146;s securities to such person. Consultants are not eligible to receive Awards under the
Plan with respect to their service in such capacity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(m)</B> &#147;<B><I>Continuous Service</I></B>&#148; means that the
Participant&#146;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an
Employee, Consultant or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, will not terminate a
Participant&#146;s Continuous Service; <I>provided, however</I>,<I> </I>that if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discretion, such Participant&#146;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. To the extent permitted by law, the Board
or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i)&nbsp;any leave of absence approved by the Board or chief executive
officer, including sick leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for
purposes of vesting in an Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(n)</B> &#147;<B><I>Corporate Transaction</I></B>&#148; means the consummation, in a single transaction or in a series of related
transactions, of any one or more of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> a sale<B> </B>or other disposition of all or substantially all, as
determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> a sale or
other disposition of more than 50% of the outstanding securities of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> a merger, consolidation or similar
transaction following which the Company is not the surviving corporation; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> a merger, consolidation or similar transaction
following which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar
transaction into other property, whether in the form of securities, cash or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If required for compliance with Section&nbsp;409A of the Code, in
no event will an event be deemed a Corporate Transaction if such event is not also a &#147;change in the ownership of&#148; the Company, a &#147;change in the effective control of&#148; the Company or a &#147;change in the ownership of a substantial
portion of the assets of&#148; the Company, each as determined under Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> (without regard to any alternative definition thereunder). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(o)</B> &#147;<B><I>Director</I></B>&#148; means a member of the Board. Directors are not eligible to receive Awards under the Plan with
respect to their service in such capacity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(p)</B> &#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, the
inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous
period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(q)</B> &#147;<B><I>Dissolution</I></B>&#148; means when the Company, after having executed a certificate of dissolution with the State of
Delaware (or other applicable state), has completely wound up its affairs. Conversion of the Company into a Limited Liability Company (or any other pass-through entity) will not be considered a &#147;Dissolution&#148; for purposes of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(r)</B> &#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate. However, service solely as a Director,
or payment of a fee for such services, will not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(s)</B> &#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited
liability company or other entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(t)</B> &#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(u)</B> &#147;<B><I>Exchange Act Person</I></B>&#148;<B><I>
</I></B>means any natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act), except that &#147;Exchange Act Person&#148; will not include (i)&nbsp;the Company or any Subsidiary of the
Company, (ii)&nbsp;any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an
underwriter temporarily holding securities pursuant to a registered public offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of
stock of the Company; or (v)&nbsp;any natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d) or 14(d) of the Exchange Act) that, as of the IPO Date, is the Owner, directly or indirectly, of securities of the Company
representing more than 50% of the combined voting power of the Company&#146;s then outstanding securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> &#147;<B><I>Fair
Market Value</I></B>&#148; means, as of any date, the value of the Common Stock determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> If the Common Stock is
listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or
market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then
the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> In the
absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(w)</B> &#147;<B><I>IPO Date</I></B>&#148; means the date of the underwriting agreement between the Company and the underwriter(s) managing
the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(x)</B>
&#147;<B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director</I></B>&#148;<B> </B>means a Director who either (i)&nbsp;is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly
or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> promulgated pursuant to the Securities Act (&#147;<B><I>Regulation <FONT STYLE="white-space:nowrap">S-K</FONT></I></B>&#148;)), does not possess an interest in any other transaction for which disclosure would be
required under Item 404(a) of Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> and is not engaged in a business relationship for which disclosure would be required pursuant to Item&nbsp;404(b) of Regulation
<FONT STYLE="white-space:nowrap">S-K;</FONT> or (ii)&nbsp;is otherwise considered a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(y)</B> &#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means any Option granted pursuant to Section&nbsp;5 of the Plan that does not
qualify as an incentive stock option within the meaning of Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(z)</B> &#147;<B><I>Officer</I></B>&#148;
means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(aa)</B> &#147;<B><I>Option</I></B>&#148; means a Nonstatutory Stock Option to purchase
shares of Common Stock granted pursuant to the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(bb)</B> &#147;<B><I>Option Agreement</I></B>&#148; means a written agreement
between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(cc)</B> &#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such
other person who holds an outstanding Option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(dd)</B> &#147;<B><I>Other Stock Award</I></B>&#148; means an award based in whole or in
part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(d). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>ee</B><B>)</B> &#147;<B><I>Other Stock Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the Company and
a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ff)</B> &#147;<B><I>Own,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owned,</I></B>&#148;<B><I> </I></B>&#147;<B><I>Owner,</I></B>&#148;<B><I>
</I></B>&#147;<B><I>Ownership</I></B>&#148;<B> </B>means a person or Entity will be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired &#147;Ownership&#148; of securities if such person or
Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(gg)</B> &#147;<B><I>Participant</I></B>&#148; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other
person who holds an outstanding Stock Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(hh)</B> &#147;<B><I>Performance Award</I></B>&#148; means a Performance Cash Award or a
Performance Stock Award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> &#147;<B><I>Performance Cash Award</I></B>&#148; means an award of cash granted pursuant to the terms
and conditions of Section&nbsp;6(c)(ii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(jj)</B> &#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria that
the Board or the Committee will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the
following as determined by the Board: (i)&nbsp;sales; (ii) revenues; (iii)&nbsp;assets; (iv) expenses; (v)&nbsp;market penetration or expansion; (vi)&nbsp;earnings from operations; (vii)&nbsp;earnings before or after deduction for all or any portion
of interest, taxes, depreciation, amortization, incentives, service fees or extraordinary or special items, whether or not on a continuing operations or an aggregate or per share basis; (viii)&nbsp;net income or net income per common share (basic or
diluted); (ix) return on equity, investment, capital or assets; (x)&nbsp;one or more operating ratios; (xi)&nbsp;borrowing levels, leverage ratios or credit rating; (xii)&nbsp;market share; (xiii)&nbsp;capital expenditures; (xiv)&nbsp;cash flow,
free cash flow, cash flow return on investment, or net cash provided by operations; (xv)&nbsp;stock price, dividends or total stockholder return; (xvi)&nbsp;development of new technologies or products; (xvii)&nbsp;sales of particular products or
services; (xviii)&nbsp;economic value created or added; (xix)&nbsp;operating margin or profit margin; (xx)&nbsp;customer acquisition or retention; (xxi)&nbsp;raising or refinancing of capital; (xxii)&nbsp;successful hiring of key individuals;
(xxiii)&nbsp;resolution of significant litigation; (xxiv)&nbsp;acquisitions and divestitures (in whole or in part); (xxv) joint ventures and strategic alliances; (xxvi)&nbsp;spin-offs, <FONT STYLE="white-space:nowrap">split-ups</FONT> and the like;
(xxvii)&nbsp;reorganizations; (xxviii) recapitalizations, restructurings, financings (issuance of debt or equity) or refinancings; (xxix)&nbsp;or strategic business criteria, consisting of one or more objectives based on the following goals:
achievement of timely development, design management or enrollment, meeting specified market penetration or value added, payor acceptance, patient adherence, peer reviewed publications, issuance of new patents, establishment of or securing of
licenses to intellectual </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
property, product development or introduction (including, without limitation, any clinical trial accomplishments, regulatory or other filings, approvals or milestones, discovery of novel
products, maintenance of multiple products in pipeline, product launch or other product development milestones), geographic business expansion, cost targets, cost reductions or savings, customer satisfaction, operating efficiency, acquisition or
retention, employee satisfaction, information technology, corporate development (including, without limitation, licenses, innovation, research or establishment of third party collaborations), manufacturing or process development, legal compliance or
risk reduction, patent application or issuance goals, or goals relating to acquisitions, divestitures or other business combinations (in whole or in part), joint ventures or strategic alliances; and (xxx)&nbsp;other measures of performance selected
by the Board or the Committee </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(kk)</B> &#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more
goals established by the Board or the Committee for the Performance Period based upon the Performance Criteria.&nbsp;Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or
business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices.&nbsp;The Board or the Committee is authorized at any time in its sole discretion,
to adjust or modify the calculation of a Performance Goal for such Performance Period in order to prevent the dilution or enlargement of the rights of Participants, (a)&nbsp;in the event of, or in anticipation of, any unusual or extraordinary
corporate item, transaction, event or development; (b)&nbsp;in recognition of, or in anticipation of, any other unusual or nonrecurring events affecting the Company, or the financial statements of the Company in response to, or in anticipation of,
changes in applicable laws, regulations, accounting principles, or business conditions; or (c)&nbsp;in view of the Board&#146;s (or Committee&#146;s) assessment of the business strategy of the Company, performance of comparable organizations,
economic and business conditions, and any other circumstances deemed relevant. Specifically, the Board is authorized to make adjustment in the method of calculating attainment of Performance Goals and objectives for a Performance Period as follows:
(i)&nbsp;to exclude the dilutive effects of acquisitions or joint ventures; (ii)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such
divestiture; and (iii)&nbsp;to exclude the effect of any change in the outstanding shares of Common Stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT
STYLE="white-space:nowrap">spin-off,</FONT> combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends. In addition, the Board or the Committee is authorized to
make adjustment in the method of calculating attainment of Performance Goals and objectives for a Performance Period as follows: (i)&nbsp;to exclude restructuring and/or other nonrecurring charges; (ii)&nbsp;to exclude exchange rate effects, as
applicable, for <FONT STYLE="white-space:nowrap">non-U.S.</FONT> dollar denominated net sales and operating earnings; (iii)&nbsp;to exclude the effects of changes to generally accepted accounting standards required by the Financial Accounting
Standards Board; (iv)&nbsp;to exclude the effects of any items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (v)&nbsp;to exclude the effects to any statutory
adjustments to corporate tax rates; and (vi)&nbsp;to make other appropriate adjustments selected by the Board or the Committee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ll)</B> &#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by the Board or the Committee over which the
attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to and the payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration,
at the sole discretion of the Board or the Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(mm)</B> &#147;<B><I>Performance Stock Award</I></B>&#148; means a Stock Award
granted under the terms and conditions of Section&nbsp;6(c)(i). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(nn)</B> &#147;<B><I>Plan</I></B>&#148; means this Equillium, Inc. 2024
Inducement Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(oo)</B> &#147;<B><I>Restricted Stock Award</I></B>&#148; means an award of shares of
Common Stock, which is granted pursuant to the terms and conditions of Section&nbsp;6(a). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(pp)</B> &#147;<B><I>Restricted Stock Award
Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms
and conditions of the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(qq)</B> &#147;<B><I>Restricted Stock Unit Award</I></B>&#148;<B><I> </I></B>means a right to receive
shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(</B><B>rr</B><B>)</B>
&#147;<B><I>Restricted Stock Unit Award Agreement</I></B>&#148;<B><I> </I></B>means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant.
Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ss)</B> &#147;<B><I>Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act or any successor to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> as in effect from time to time.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(tt)</B> &#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(uu)</B> &#147;<B><I>Stock Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148;<B><I> </I></B>means a right to receive the
appreciation on Common Stock that is granted pursuant to the terms and conditions of Section&nbsp;5. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(vv)</B> &#147;<B><I>Stock
Appreciation Right Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will
be subject to the terms and conditions of the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ww)</B> &#147;<B><I>Stock Award</I></B>&#148; means any right to receive Common
Stock granted under the Plan, including a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance Stock Award or any Other Stock Award. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(xx)</B> &#147;<B><I>Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing the
terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(yy)</B> &#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i)&nbsp;any corporation of which more than 50% of the
outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting
power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest
(whether in the form of voting or participation in profits or capital contribution) of more than 50%. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(zz)</B>
&#147;<B><I>Transaction</I></B>&#148; means a Corporate Transaction or a Change in Control. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><I>Standard Form </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>QUILLIUM</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>S<SMALL>TOCK</SMALL> O<SMALL>PTION</SMALL> G<SMALL>RANT</SMALL> N<SMALL>OTICE</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(2024 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL>) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Equillium, Inc. (the &#147;<B><I>Company</I></B>&#148;), pursuant to its 2024 Inducement Plan<B> </B>(the &#147;<B><I>Plan</I></B>&#148;), hereby grants to
Optionholder an option to purchase the number of shares of the Company&#146;s Common Stock set forth below. This option is subject to all of the terms and conditions as set forth in this Stock Option Grant Notice, in the Option Agreement, the Plan
and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined herein but defined in the Plan or the Option Agreement will have the same definitions as in the Plan or
the Option Agreement. If there is any conflict between the terms in this Stock Option Grant Notice and the Plan, the terms of the Plan will control. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Optionholder:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Number of Shares Subject to Option:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exercise Price (Per Share):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Exercise Price:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Expiration Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Type of Grant:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Nonstatutory Stock Option</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Exercise Schedule:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Same as Vesting Schedule</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vesting Schedule:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">[One-fourth</FONT> (1/4th) of the shares vest one year after the Vesting Commencement Date; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the
first anniversary of the Vesting Commencement Date], subject to Optionholder&#146;s Continuous Service as of each such date</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Payment:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">By one or a combination of the following items (described in the Option Agreement):</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#9746;&#8194;&#8201;&#8201;By cash, check, bank draft or money order payable to the
Company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#9746;&#8194;&#8201;&#8201;Pursuant to a Regulation T Program if the shares are publicly
traded</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#9746;&#8194;&#8201;&#8201;By delivery of already-owned shares if the shares are publicly
traded</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">&#9746;&#8194;&#8201;&#8201;Subject to the Company&#146;s consent at the time of exercise, by a
&#147;net exercise&#148; arrangement</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1. </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Terms/Acknowledgements:</B> Optionholder acknowledges receipt of, and understands and agrees
to, this Stock Option Grant Notice, the Option Agreement and the Plan. Optionholder acknowledges and agrees that this Stock Option Grant Notice and the Option Agreement may not be modified, amended or revised except as provided in the Plan.
Optionholder further acknowledges that as of the Date of Grant, this Stock Option Grant Notice, the Option Agreement, and the Plan set forth the entire understanding between Optionholder and the Company regarding this option award and supersede all
prior oral and written agreements, promises and/or representations on that subject with the exception of, if applicable, (i)&nbsp;equity awards previously granted and delivered to Optionholder, (ii)&nbsp;any compensation recovery policy that is
adopted by the Company or is otherwise required by applicable law and (iii)&nbsp;any written employment or severance arrangement or other written agreement entered into between the Company and Optionholder specifying the terms that should govern
this option upon the terms and conditions set forth therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By accepting this option, Optionholder acknowledges having received and read the Stock
Option Grant Notice, the Option Agreement and the Plan and agrees to all of the terms and conditions set forth in these documents. Optionholder consents to receive Plan and related documents by electronic delivery and to participate in the Plan
through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by the Company or another third party designated by the Company. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>E<SMALL>QUILLIUM</SMALL>, I<SMALL>NC</SMALL>.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>O<SMALL>PTIONHOLDER</SMALL>:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Signature</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A<SMALL>TTACHMENTS</SMALL></B><SMALL></SMALL>: Option Agreement, 2024 Inducement Plan<B> </B>and Notice of Exercise </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>TTACHMENT</SMALL> I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>E<SMALL>QUILLIUM</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>O<SMALL>PTION</SMALL> A<SMALL>GREEMENT</SMALL> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(2024 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL>) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(N<SMALL>ONSTATUTORY</SMALL> S<SMALL>TOCK</SMALL> O<SMALL>PTION</SMALL>) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to your Stock Option Grant Notice (&#147;<B><I>Grant Notice</I></B>&#148;) and this Option Agreement, Equillium, Inc. (the
&#147;<B><I>Company</I></B>&#148;) has granted you an option under its 2024 Inducement Plan (the &#147;<B><I>Plan</I></B>&#148;) to purchase the number of shares of the Company&#146;s Common Stock indicated in your Grant Notice at the exercise price
indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the &#147;<B><I>Date of Grant</I></B>&#148;). If there is any conflict between the terms in this Option Agreement and the
Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The details of your option, in addition to those set forth in the Grant Notice and the Plan, are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.</B> <B>V<SMALL>ESTING</SMALL></B><SMALL></SMALL>. Your option will vest as provided in your Grant Notice. Vesting will cease upon the
termination of your Continuous Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.</B> <B>N<SMALL>UMBER</SMALL> <SMALL>OF</SMALL> S<SMALL>HARES</SMALL> <SMALL>AND</SMALL>
E<SMALL>XERCISE</SMALL> P<SMALL>RICE</SMALL>.</B> The number of shares of Common Stock subject to your option and your exercise price per share in your Grant Notice will be adjusted for Capitalization Adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <B>E<SMALL>XERCISE</SMALL> R<SMALL>ESTRICTION</SMALL> <SMALL>FOR</SMALL>
N<SMALL>ON</SMALL><FONT STYLE="white-space:nowrap">-E</FONT><SMALL>XEMPT</SMALL> E<SMALL>MPLOYEES</SMALL>.</B> If you are an Employee eligible for overtime compensation under the Fair Labor Standards Act of 1938, as amended (that is, a &#147;<B><I><FONT
STYLE="white-space:nowrap">Non-Exempt</FONT> Employee</I></B>&#148;), and except as otherwise provided in the Plan, you may not exercise your option until you have completed at least six (6)&nbsp;months of Continuous Service measured from the Date
of Grant, even if you have already been an employee for more than six (6)&nbsp;months. Consistent with the provisions of the Worker Economic Opportunity Act, you may exercise your option as to any vested portion prior to such six (6)&nbsp;month
anniversary in the case of (i)&nbsp;your death or disability, (ii)&nbsp;a Corporate Transaction in which your option is not assumed, continued or substituted, (iii)&nbsp;a Change in Control or (iv)&nbsp;your termination of Continuous Service on your
&#147;retirement&#148; (as defined in the Company&#146;s benefit plans). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B>M<SMALL>ETHOD</SMALL> <SMALL>OF</SMALL>
P<SMALL>AYMENT</SMALL>.</B> You must pay the full amount of the exercise price for the shares you wish to exercise. You may pay the exercise price in cash or by check, bank draft or money order payable to the Company or in any other manner
<B><I>permitted by your Grant Notice,</I></B> which may include one or more of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Provided that at the time of
exercise the Common Stock is publicly traded, pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of Common Stock, results in either the receipt of cash (or check) by the Company
or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds. This manner of payment is also known as a &#147;broker-assisted exercise&#148;, &#147;same day sale&#148;, or &#147;sell to
cover&#148;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Provided that at the time of exercise the Common Stock is publicly traded, by
delivery to the Company (either by actual delivery or attestation) of already-owned shares of Common Stock that are owned free and clear of any liens, claims, encumbrances or security interests, and that are valued at Fair Market Value on the date
of exercise. &#147;Delivery&#148; for these purposes, in the sole discretion of the Company at the time you exercise your option, will include delivery to the Company of your attestation of ownership of such shares of Common Stock in a form approved
by the Company. You may not exercise your option by delivery to the Company of Common Stock if doing so would violate the provisions of any law, regulation or agreement restricting the redemption of the Company&#146;s stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> Subject to the consent of the Company at the time of exercise, by a &#147;net exercise&#148; arrangement pursuant to which the
Company will reduce the number of shares of Common Stock issued upon exercise of your option by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price. You must pay any remaining balance of the
aggregate exercise price not satisfied by the &#147;net exercise&#148; in cash or other permitted form of payment. Shares of Common Stock will no longer be outstanding under your option and will not be exercisable thereafter if those shares
(i)&nbsp;are used to pay the exercise price pursuant to the &#147;net exercise,&#148; (ii) are delivered to you as a result of such exercise, and (iii)&nbsp;are withheld to satisfy your tax withholding obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>W<SMALL>HOLE</SMALL> S<SMALL>HARES</SMALL>.</B> You may exercise your option only for whole shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B> <B>S<SMALL>ECURITIES</SMALL> L<SMALL>AW</SMALL> C<SMALL>OMPLIANCE</SMALL>.</B> In no event may you exercise your option unless the
shares of Common Stock issuable upon exercise are then registered under the Securities Act or, if not registered, the Company has determined that your exercise and the issuance of the shares would be exempt from the registration requirements of the
Securities Act. The exercise of your option also must comply with all other applicable laws and regulations governing your option, and you may not exercise your option if the Company determines that such exercise would not be in material compliance
with such laws and regulations (including any restrictions on exercise required for compliance with Treas. Reg. <FONT STYLE="white-space:nowrap">1.401(k)-1(d)(3),</FONT> if applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7.</B> <B>T<SMALL>ERM</SMALL>.</B> You may not exercise your option before the Date of Grant or after the expiration of the option&#146;s
term. The term of your option expires, subject to the provisions of Section&nbsp;5(h) of the Plan, upon the earliest of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> immediately upon the termination of your Continuous Service for Cause; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> three (3)&nbsp;months after the termination of your Continuous Service for any reason other than Cause,<B> </B>your Disability or
your death (except as otherwise provided in Section&nbsp;7(d) below); <I>provided, however, </I>that if during any part of such three (3)&nbsp;month period your option is not exercisable solely because of the condition set forth in the section above
regarding &#147;Securities Law Compliance,&#148; your option will not expire until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3)&nbsp;months after the termination of your Continuous Service;
<I>provided further,</I> if during any part of such three (3)&nbsp;month period, the sale of any shares of Common Stock received upon exercise of your option would violate the Company&#146;s insider trading policy, then your option will not expire
until the earlier of the Expiration Date or until it has been exercisable for an aggregate period of three (3)&nbsp;months after the termination of your Continuous Service during which the sale of the shares of Common Stock received upon exercise of
your option would not be in violation of the Company&#146;s insider trading policy. Notwithstanding the foregoing, if (i)&nbsp;you are a <FONT STYLE="white-space:nowrap">Non-Exempt</FONT> Employee, (ii)&nbsp;your Continuous Service terminates within
six (6)&nbsp;months after the Date of Grant, and (iii)&nbsp;you have vested in a portion of your option at the time of your termination of Continuous Service, your option will not expire until the earlier of (x)&nbsp;the later of (A)&nbsp;the date
that is seven (7)&nbsp;months after the Date of Grant, and (B)&nbsp;the date that is three (3)&nbsp;months after the termination of your Continuous Service, and (y)&nbsp;the Expiration Date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> twelve (12)&nbsp;months after the termination of your Continuous Service due to
your Disability (except as otherwise provided in Section&nbsp;7(d) below); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> eighteen (18)&nbsp;months after your death if you
die either during your Continuous Service or within three (3)&nbsp;months after your Continuous Service terminates for any reason other than Cause; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> the Expiration Date indicated in your Grant Notice; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> the day before the tenth (10th) anniversary of the Date of Grant. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>E<SMALL>XERCISE</SMALL>. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> You may exercise the vested portion of your option during its term by (i)&nbsp;delivering a Notice of Exercise (in a form designated
by the Company) or completing such other documents and/or procedures designated by the Company for exercise and (ii)&nbsp;paying the exercise price and any applicable withholding taxes to the Company&#146;s Secretary, stock plan administrator, or
such other person as the Company may designate, together with such additional documents as the Company may then require. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> By
exercising your option you agree that, as a condition to any exercise of your option, the Company may require you to enter into an arrangement providing for the payment by you to the Company of any tax withholding obligation of the Company arising
by reason of (i)&nbsp;the exercise of your option, (ii)&nbsp;the lapse of any substantial risk of forfeiture to which the shares of Common Stock are subject at the time of exercise, or (iii)&nbsp;the disposition of shares of Common Stock acquired
upon such exercise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.</B> <B>T<SMALL>RANSFERABILITY</SMALL>.</B> Except as otherwise provided in this Section&nbsp;9, your option is
not transferable, except by will or by the laws of descent and distribution, and is exercisable during your life only by you. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B>
<B>Certain Trusts.</B> Upon receiving written permission from the Board or its duly authorized designee, you may transfer your option to a trust if you are considered to be the sole beneficial owner (determined under Section&nbsp;671 of the Code and
applicable state law) while the option is held in the trust. You and the trustee must enter into transfer and other agreements required by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> <B>Domestic Relations Orders.</B> Upon receiving written permission from the Board or its duly authorized designee, and provided
that you and the designated transferee enter into transfer and other agreements required by the Company, you may transfer your option pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or
separation instrument as permitted by Treasury Regulation <FONT STYLE="white-space:nowrap">1.421-1(b)(2)</FONT> that contains the information required by the Company to effectuate the transfer. You are encouraged to discuss the proposed terms of any
division of this option with the Company prior to finalizing the domestic relations order or marital settlement agreement to help ensure the required information is contained within the domestic relations order or marital settlement agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> <B>Beneficiary Designation.</B> Upon receiving written permission from the Board or its duly authorized designee, you may, by
delivering written notice to the Company, in a form approved by the Company and any broker designated by the Company to handle option exercises, designate a third party who, on your death, will thereafter be entitled to exercise this option and
receive the shares of Common Stock or other consideration resulting from such exercise. In the absence of such a designation, your executor or administrator of your estate will be entitled to exercise this option and receive, on behalf of your
estate, the shares of Common Stock or other consideration resulting from such exercise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.</B> <B>O<SMALL>PTION</SMALL> <SMALL>NOT</SMALL> <SMALL>A</SMALL>
S<SMALL>ERVICE</SMALL> C<SMALL>ONTRACT</SMALL>.</B> Your option is not an employment or service contract, and nothing in your option will be deemed to create in any way whatsoever any obligation on your part to continue in the employ of the Company
or an Affiliate, or of the Company or an Affiliate to continue your employment. In addition, nothing in your option will obligate the Company or an Affiliate, their respective stockholders, boards of directors, officers or employees to continue any
relationship that you might have as a Director or Consultant for the Company or an Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11. W<SMALL>ITHHOLDING</SMALL>
O<SMALL>BLIGATIONS</SMALL>. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> At the time you exercise your option, in whole or in part, and at any time thereafter as
requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a &#147;same day sale&#148; pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or an Affiliate, if any, which arise in
connection with the exercise of your option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Upon your request and subject to approval by the Company, and compliance with any
applicable legal conditions or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon the exercise of your option a number of whole shares of Common Stock having a Fair Market Value, determined
by the Company as of the date of exercise, not in excess of the maximum amount of tax permitted to be withheld by law (or such lower amount as may be necessary to avoid classification of your option as a liability for financial accounting purposes).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> You may not exercise your option unless the tax withholding obligations of the Company and/or any Affiliate are satisfied.
Accordingly, you may not be able to exercise your option when desired even though your option is vested, and the Company will have no obligation to issue a certificate for such shares of Common Stock or release such shares of Common Stock from any
escrow provided for herein, if applicable, unless such obligations are satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>12.</B> <B>T<SMALL>AX</SMALL>
C<SMALL>ONSEQUENCES</SMALL></B><SMALL></SMALL>. You hereby agree that the Company does not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes your tax liabilities. You will not make any claim
against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from your option or your other compensation. In particular, you acknowledge that this option is exempt from Section&nbsp;409A of the
Code only if the exercise price per share specified in the Grant Notice is at least equal to the &#147;fair market value&#148; per share of the Common Stock on the Date of Grant and there is no other impermissible deferral of compensation associated
with the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>13.</B> <B>N<SMALL>OTICES</SMALL>.</B> Any notices provided for in your option or the Plan will be given in writing
(including electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5)&nbsp;days after deposit in the United States mail, postage prepaid, addressed to you at the
last address you provided to the Company. The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this option by electronic means or to request your consent to participate in the Plan by
electronic means. By accepting this option, you consent to receive such documents by electronic delivery and to participate in the Plan through an <FONT STYLE="white-space:nowrap">on-line</FONT> or electronic system established and maintained by the
Company or another third party designated by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>14.</B> <B>G<SMALL>OVERNING</SMALL> P<SMALL>LAN</SMALL> D<SMALL>OCUMENT</SMALL>.</B> Your
option is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your option, and is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and
adopted pursuant to the Plan. If there is any conflict between the provisions of your option and those of the Plan, the provisions of the Plan will control. In addition, your option (and any compensation paid or shares issued under your option) is
subject to recoupment in accordance with The Dodd&#150;Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted by the Company and any compensation recovery policy otherwise
required by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>15.</B> <B>O<SMALL>THER</SMALL> D<SMALL>OCUMENTS</SMALL>. </B>You hereby acknowledge receipt of and the
right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus. In addition, you acknowledge receipt of the Company&#146;s policy permitting certain
individuals to sell shares only during certain &#147;window&#148; periods and the Company&#146;s insider trading policy, in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>16.</B> <B>E<SMALL>FFECT</SMALL> <SMALL>ON</SMALL> O<SMALL>THER</SMALL> E<SMALL>MPLOYEE</SMALL> B<SMALL>ENEFIT</SMALL>
P<SMALL>LANS</SMALL>.</B> The value of this option will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any Affiliate, except
as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company&#146;s or any Affiliate&#146;s employee benefit plans. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17.</B> <B>V<SMALL>OTING</SMALL> R<SMALL>IGHTS</SMALL>.</B> You will not have voting or any other rights as a stockholder of the Company
with respect to the shares to be issued pursuant to this option until such shares are issued to you. Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company. Nothing contained in this option, and no action
taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>18.</B> <B>S<SMALL>EVERABILITY</SMALL>.</B> If all or any part of this Option Agreement or the Plan is declared by any court or
governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Option Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Option Agreement (or part of such a
Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>19.</B> <B>M<SMALL>ISCELLANEOUS</SMALL></B><SMALL></SMALL>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The rights and obligations of the Company under your option will be transferable to any one or more persons or entities, and all
covenants and agreements hereunder will inure to the benefit of, and be enforceable by the Company&#146;s successors and assigns. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the
Company to carry out the purposes or intent of your option. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> You acknowledge and agree that you have reviewed your option in its
entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your option, and fully understand all provisions of your option. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> This Option Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental
agencies or national securities exchanges as may be required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> All obligations of the Company under the Plan and this Option Agreement will be
binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option Agreement
will be deemed to be signed by you upon the signing by you of the Stock Option Grant Notice to which it is attached. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>TTACHMENT</SMALL> II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2024 I<SMALL>NDUCEMENT</SMALL> P<SMALL>LAN</SMALL> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>TTACHMENT</SMALL> III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> E<SMALL>XERCISE</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>E<SMALL>QUILLIUM</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2223 Avenida de la Playa, Suite 108</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Date of Exercise: _______________</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">La Jolla, California 92037 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This constitutes notice to Equillium, Inc. (the &#147;<B><I>Company</I></B>&#148;) under my stock option that I elect to purchase the below
number of shares of Common Stock of the Company (the&nbsp;&#147;<B><I>Shares</I></B>&#148;) for the price set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Type of option:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">Nonstatutory</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock option dated:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Shares as <BR>to which option is <BR>exercised:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificates to be <BR>issued in name of:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total exercise price:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash payment delivered <BR>herewith:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[Value of ________ Shares delivered
herewith<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<U></U></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><U>&#8195;&#8195;&#8195;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<U></U></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><U>&#8195;&#8195;&#8195;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[Value of ________ Shares pursuant to net
exercise<SUP STYLE="font-size:75%; vertical-align:top">2</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<U></U></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><U>&#8195;&#8195;&#8195;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<U></U></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><U>&#8195;&#8195;&#8195;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">]&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[Regulation T Program (cashless
exercise<SUP STYLE="font-size:75%; vertical-align:top">3</SUP>):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<U></U></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><U>&#8195;&#8195;&#8195;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$<U></U></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><U>&#8195;&#8195;&#8195;</U>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">]&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By this exercise, I agree (i)&nbsp;to provide such additional documents as you may require pursuant to the
terms of the Equillium, Inc. 2024 Inducement Plan and (ii)&nbsp;to provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the exercise of this option. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares must meet the public trading requirements set forth in the option. Shares must be valued in accordance
with the terms of the option being exercised, and must be owned free and clear of any liens, claims, encumbrances or security interests. Certificates must be endorsed or accompanied by an executed assignment separate from certificate.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company must have established net exercise procedures at the time of exercise, in order to utilize this
payment method. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares must meet the public trading requirements set forth in the option. </P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>eq-20240306.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/9/2024 1:47:19 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:eq="http://equilliumbio.com/20240306"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://equilliumbio.com/20240306"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eq-20240306_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="eq-20240306_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>eq-20240306_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/9/2024 1:47:19 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>eq-20240306_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 3/9/2024 1:47:19 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="eq-20240306.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140419549443440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001746466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  06,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Equillium, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-1554746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2223 Avenida de la<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Playa<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">La Jolla<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">412-5302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M K\,>H-?,91Z;?!Q#W]6 8S*+%():KZX2->GE[V.AWDOK9<#BCOY-]@6&I[
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ ((!H6)>*NQS
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M"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ ((!H6 =!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  @@&A8
M%_+Z#>T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    "  @@&A8F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "" :%AU16N_= 0
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M2P$"% ,4    "  @@&A8)!Z;HJT   #X 0  &@              @ 'G$0
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  @@&A899!Y
MDAD!  #/ P  $P              @ ',$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"   6%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d797682d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d797682d8k.htm">d797682d8k.htm</File>
    <File>eq-20240306.xsd</File>
    <File>eq-20240306_lab.xml</File>
    <File>eq-20240306_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d797682d8k.htm": {
   "nsprefix": "eq",
   "nsuri": "http://equilliumbio.com/20240306",
   "dts": {
    "inline": {
     "local": [
      "d797682d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "eq-20240306.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "eq-20240306_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "eq-20240306_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-03-06_to_2024-03-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d797682d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-03-06_to_2024-03-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d797682d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://equilliumbio.com//20240306/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-063618-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-063618-xbrl.zip
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ME]TI)?4Q@KTR*5_VJ-0) =9T7]B0J[/-0Q[(F8\6NU2+G':R>I6EQ6&QG(!
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M\WXV;^=LUE2T;!-+G!?U_W-'_>]X&O\/4$L#!!0    ( "" :%@B?FE"V(8
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MS^$4H7:@T 'A<8PR8S.+=N06[>YE44T+IUZUX>I5H>2'TZU@_,.?V?SP4[^
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M_O?<B<Z2[&"&84\RXA%1:F2#*A:LY+:AL<P3YD_W6[3$95$&]K2?4U#]&8B
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M2(L'-GFQEUHT?*AQ,D>;F+Y 4Z>]%^W'U5M10'?5!?)\B-C%>R6:U-K"OFS
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M^W6&Y&_5Y%K6D>E!J-U;U2F 7W/^X5??[^VSH_'EELBQ#Y.?0*HK^L$<;0@
M*TQA0E]'FO+>Z.6R5-9._LZJFLM8:-FO!0H^D[0XK\I)"OT7N94KP5HBN,X?
M):N+-*NLN]E(6!'G1!G[F9RJA7MV6A:7C+*5_!_GF SL!/0AA'V#/G/GK&+7
M5J!TTRNA]<CJADA/^43@C:,C$@P]N3=0OLAW-D$YEG! Y=$&Y8&O&I^9UMX
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M@+$H$+:9A7V6J'Q@,&HW/O]X=W_D\<=C3Z"QE<>?$20;.0//$Q01ML;?JN*
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M)K2AB"[$DK=1'H,[YG;=[;#&W?U2"\6G#?:WADY$](B+A&HT4BWGL&C&6$$
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MNYX8"%VAF=W&O<AQ;>-BI2"Q>$NIE1SYU\ ;70)Q2-$O([]<5_%&B8(Y@KR
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M29UJ,$EBR+P=21E&H=NSORDC8Y=DO90ED*662KZM0VR< Z*0+[RR '6P[V^
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M?>])7(LQD-Z^5_+NJMN,?],?,W;F$)U*IV*QXJF]X!#L>\Q^8%1KSW*1R?[
M^X8KIQ>EK1K5O].Q,'+U0_X_CY,XV%J4&#8AREXMUV*XO-X/O1C10R!AOH/>
M((E'R@HT2!.@ZXGKVOR;9&:3.Q[AB05WRR'4_ 7S/R9H1!D%51CZC"3KYR-P
M? $%W.L1]"!5_AREI%#F#-K&I+E>PNQL'C^[\.?7!@T7:Z3>][NK:R2@2X:H
M$&.&3]!K'%\_1V[[43?VTTTSZ>=G[)3).!V@20SLD^4E-9"&R?AK+B#HA13-
MX47=52FZ/DW;V#V^)J#_^M<W'][^80Z^/_S[;UO_ U!+ P04    "  @@&A8
M-:B]"C\#  !%"P  #P   &5Q+3(P,C0P,S V+GAS9+U636_;.!"]%^A_F.JT
M"U2B9:<M+,0ILIL&")"FA9L6>RMH:>P02Y$*227QO^^0DAS%CETG6:POICGS
M'M]\<.C#CW>EA!LT5F@UB=)D$ &J7!="+291;6-N<R&BCT>O7QV^B6,X.3V[
M@!BNG*MLQMCM[6U2S(6R6M:.&&R2ZY)!''?^?U]^AQ\->P93E,@M0LFM0P-_
MU4(6V7 P'*6#=)@,^S"#W/-!P1UF,&)C1GX'D&8''[)T#,>?X5,@47 I2NPC
M=;4T8G'EX(_\3PB@$ZT42HE+.!6*JUQP"=\ZP6_A3.4)'$L)4P^SI-*BN<$B
M:5GO;)'9_ I+_OH5 *5+V4P195U.(I^'-@UW,R,3;1:L<(:Y986,G&+R0B/R
MJ ?]/6X#0W7P%KL"SKF=!5!G\>D9]1!XO?+%:\JS%'4Y$SJ4QR=E,!J\[[D7
M*%;^09#%/%GH&T:&=6IO%X^',!P,1HRZP5&6L0>10OV[ ^'-,VJ,_B$;D-M1
M *3C\9@%ZYJDPCV,H&5_QQIC\.;.&3&K'9YJ4Y[@G->24+6ZKKD4<X%%\*(N
M+5&Y!SX//1PW"W07O$1;\1R?E&IJI\?B(JDI^^?S^;?0:=&1!P"$YA-EI8V#
MI@?/=1YNQHYT^E]Q5X78;\7I,!ZE"9%%H#94[R@AL!<+Z8K[+"&KSMA;B-W6
MP7X1^\6VTQ_O^V=G8/TZ^_C'/O[T_5[Q;XR#_T")5A<O%=.;:<^OB>(B;T96
ML]R_+O?(%_5F-Q5\'M[M/'A]C+2GAC.Y4MJ%@_I*>%4)-=?M%FWZ)LZZ3I[B
M',+XRKC)C9:X>\BQRN@*C1,TXN\O0T-P97 ^B? Z[J;,3\EG"4V9SF&#_N'E
M\F9&$)3G]^(ZK!/.@\^]&;R=7DHN5]2^&2:1I:S+WN7\7X.M##XU6()8FNRA
M9-MC_MKS>G+H_IQ+\@"_^#X]V_XVK!X'YOB=5KI<-B)/=%[[]Z?[/E;%)T72
MEF?45:8,LB(0](I,R?WG7NXKD9W, NE?FPBMFP[\A_[4=0S])5<%-'30XSMD
MZR3K_+7%XHLZ"NN<R[R6JZ2WX-9C%W"]7/LC[Y5MQ[6[7<&Z*\S6[W"[T[_K
MS58S:^CG+U!+ P04    "  @@&A8_+0.L)T&  "W20  $P   &5Q+3(P,C0P
M,S V7VQA8BYX;6S-G&]OVS80QM\7Z'>X>6\VH+)CN\ 0HVF1.<D0+&V"QMV&
M#4,A2XQ-3"8-2H[M;S]2?QHYIF0J/%9^T5:1[IZ[1_F=*TNFWWW8+")X)"*F
MG)UU^MV3#A 6\)"RV5EG%7M^'%#:@3CQ6>A'G)&SSI;$G0_O7[]Z]X/GP<75
M]2?P8)XDRWC4ZZW7ZV[X0%G,HU4B)>-NP!<]\+PB?CSY G]DY4;PF43$CPDL
M_#@A GY=T2@<#4X&P_Y)?] =E-,$\94>A'Y"1C#LG?9DW%OHC][^,NJ?POE'
MN$Q%&$SH@I0S^7(KZ&R>P$_!SY F77#&2!21+5Q1YK. ^A'<%PV_@6L6=.$\
MBN"S2HMEES$1CR3LYJH19?^-U%]3U3N\?@4@3R*+TWUG'74J\C.QF8JHR\5,
M]GHR[!4IG:>,S5[*>I@F]$]/3WOIT7)T3'6Q4KS?^^OCS7TP)PO?DR=?_K*"
MO$Q,1W&Z_X8'Z1DT:! J(]1/7A'FJ5U>?^ -^]U-'';>JX+YV?&G)+J16Y!Z
M& D>D9K"ZG!:O9/')]NEC">;A+"0Y,K?M'F01\T%><A4%7JI9$R"[HP_]D)"
M%2!#M>&I#=7AC_*'KV,N:3^?QHGP@V2W7J1.$1?%SM3$64>3U-MM2,6=BV!'
MRQ=!H2,W#_C/(WH!E[^W9>*EBD7Z@^ +;1=Y.:XY^#6:1MHV%4ER2PTW8=Z7
M^T->,Z&R,4%BOA(2KR:_VM3/^U09_BFT_WW7>ZI]+*W*EY"8W#3MUP[)>Q*L
M!$VVEYM@+OV23_Z"F)*ISVT)T%HCO#K&!M=J/21JBP)05 !5PII==WV7$6[:
MO!W(YPOY>BW_)%>1/S,E^%E22^CJ6^>:@S:P:H20*/VF#$K:FDX'C9:Q-.W6
M#L=+EDCTQ[*,\*-K>26Q^9UL3;&L2&X)SWHKO";(!M<:021LLPJ0EX"T!L@B
MU@ [;+T,<O/^[9"^X,%*S<U$=F]*\FY.2P!K&^?[QVQPW==!HK00!J5LC29^
MFV4B#7O%P?".",K#2Q9>R+?E37E\EMPRF'HKO"8( U6-(#:S60F0-4 50</7
M0>M:CHW[Q[A8^$QF5+W;8TF3-V'ZW%8O%2J,\.H8^PL%G1[N=<)3!9PW8>[Z
MUEPD&#>/ ?(U"[A8<I'>\[M/Y.",^4I>I&S'/&S(]0&I5C$WL\F-4^R'P$ >
M=R9V"D):$?*2H&HB#<EW\*69F9>;PQBB*QJ13ZO%E(AF$U/.:W4\- :X_K@]
M^,^U<"E7ZI#)(P&-W:^&7J.F,4"=^)OK4%XLT0>:/>5Y";65(JTB?,@:-PBV
MA[M6&)=T60IV:^%R[]2*9@A>X =C),[#4!J(\W]N*"/]9N.@%6AU%.HL\0.!
M]B-0*8J+?Z[_IM@ 50EN&=9UC#,;&O1?X,4-^@-;] ='A_[ %/V!"_0'WP_]
MR9H[0Q_)AC'ZM5[<H#^T17]X=.@/3=$?ND!_^!W1ER2X>]U',F(.?[T;1/S'
M<O-63/B:O0C^<OHQH*^QHP/_*0P-^^>2CJ!798 +4(5P<<<V4 >[F0M$S-/;
M0;?B3O!'RH*&=S6K-(X!^"IC.NJ?Q:*AK]5UQ']V7T^B4U3#'0(G5NHFH8$?
MQ'&XXW'B1W_39?-;_'J%8Q@%O2G=(.Q$HHV!1M71$&250);"O&WOSD;= !A[
ML?PLMS(HB-\$^-V<MC[)K6N<[Q^S^ASWG@X2N.G_\TH9AU/\/G<^PVW8K!V(
M:G%%=#?GK.'CHOV\EH"L-,#UQVW U&LAP9F*0ZJ.==O<3;]E2)LT;0?JGX(F
M"6%COEBL6'X[/C:EM2*Y)63KK?":(!MX:P21",XKP&X):XH=-EY&N6GWEBMG
M>$0#FE V^RBON 7U(U.6=9EMK9JI-L&K(JQ6S%2H(?'[) ^%OOUB&4<M[RR5
M:=*W';9W@JCY(!*+](/ :I6CN'UX,+]PJ%-H"6,#4_Q0I W6AU21\)9EH%P'
MLD*05K(&W;6),O O=(**_G4<KXBP'P"-SG&,0;5!_3#LQ2..1(6VJ\'(RCF=
M#T>.:J>DD2V<A<']P71"DZCQHN"GO)87!.\9X/KC& N!=[6P+FJ*=;12'5)Y
MM 7 N/UJ%_\:-&T'ZD3XZAM#[K>+*3>^!'^6U!*B^M:YYJ -G!HA)#)S9<BD
MK:ETT&@92=-N,1Z+7"Z(F,EBOPF^3N;R-7SILX;+?RLD6GTP4F^+'PRU?S12
M(XO[;*0H!%DER$LA/1IQ:$/S;,342WG'C=Q2WSB4[Z+9]^[(/?\#4$L#!!0
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M.#)D97@Y.3$N:'1M4$L! A0#%     @ ((!H6#6HO0H_ P  10L   \
M         ( !X)@  &5Q+3(P,C0P,S V+GAS9%!+ 0(4 Q0    ( "" :%C\
MM ZPG08  +=)   3              "  4R<  !E<2TR,#(T,#,P-E]L86(N
M>&UL4$L! A0#%     @ ((!H6#-GY'C9!   _RT  !,              ( !
M&J,  &5Q+3(P,C0P,S V7W!R92YX;6Q02P4&      4 !0 Z 0  )*@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d797682d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="eq-20240306.xsd" xlink:type="simple"/>
    <context id="duration_2024-03-06_to_2024-03-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001746466</identifier>
        </entity>
        <period>
            <startDate>2024-03-06</startDate>
            <endDate>2024-03-06</endDate>
        </period>
    </context>
    <dei:SecurityExchangeName
      contextRef="duration_2024-03-06_to_2024-03-06"
      id="Hidden_dei_SecurityExchangeName">NASDAQ</dei:SecurityExchangeName>
    <dei:AmendmentFlag contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-263">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-03-06_to_2024-03-06"
      id="Hidden_dei_EntityCentralIndexKey">0001746466</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-274">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-275">2024-03-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-276">Equillium, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-277">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-278">001-38692</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-279">82-1554746</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-280">2223 Avenida de la</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-281">Playa</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-282">Suite 105</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-283">La Jolla</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-284">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-285">92037</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-286">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-287">412-5302</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-288">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-289">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-290">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-291">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-292">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-293">EQ</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-03-06_to_2024-03-06" id="ixv-294">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
